Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation
Transaction sharpens strategic focus on leading Academia & Government and Intellectual Property segments Proceeds strengthen balance sheet and enhance financial flexibility LONDON, Oct. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading global...
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


